[Elsevier] Efficacy and safety of once-weekly semaglutide 2﹞4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial

Sweetums33 Post time 2026-10-17 11:43:54 | Show all posts |Read mode
This post will be closed automatically in 2026-10-20 11:43
Reward100points

Title: Efficacy and safety of once-weekly semaglutide 2﹞4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
DOI: https://doi.org/10.1016/s2213-8587(26)00133-6
Please don't upload any wrong document

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
lukedap Post time 2026-10-17 11:43:55 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    155502

Return to the list